Cargando…
Improving the efficiency of clinical trials in multiple sclerosis
BACKGROUND: Phase 3 clinical trials for disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) have utilized a limited number of conventional designs with a high degree of success. However, these designs limit the types of questions that can be addressed, and the time and cost...
Autores principales: | Marrie, Ruth Ann, Sormani, Maria Pia, Apap Mangion, Sean, Bovis, Francesca, Cheung, Winson Y, Cutter, Gary R, Feys, Peter, Hill, Michael D, Koch, Marcus Werner, McCreary, Morgan, Mowry, Ellen M, Park, Jay JH, Piehl, Fredrik, Salter, Amber, Chataway, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413792/ https://www.ncbi.nlm.nih.gov/pubmed/37555492 http://dx.doi.org/10.1177/13524585231189671 |
Ejemplares similares
-
Assessing heterogeneity of treatment effect in multiple sclerosis trials
por: Sormani, Maria Pia, et al.
Publicado: (2023) -
Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021) -
Health Literacy Association With Health Behaviors and Health Care Utilization in Multiple Sclerosis: A Cross-Sectional Study
por: Marrie, Ruth Ann, et al.
Publicado: (2014) -
Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021) -
Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)